ST6GAL1 Is a Novel Serum Biomarker for Lenvatinib-Susceptible FGF19-Driven Hepatocellular Carcinoma

伦瓦提尼 肝细胞癌 FGF19型 内科学 医学 肿瘤科 肝细胞癌 生物标志物 癌症研究 生物 成纤维细胞生长因子 索拉非尼 受体 遗传学
作者
Yuta Myojin,Takahiro Kodama,Kazuki Maesaka,Daisuke Motooka,Yu Sato,Satoshi Tanaka,Yuichi Abe,Kazuyoshi Ohkawa,Eiji Mita,Yoshito Hayashi,Hayato Hikita,Ryotaro Sakamori,Tomohide Tatsumi,Ayumu Taguchi,Hidetoshi Eguchi,Tetsuo Takehara
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
卷期号:27 (4): 1150-1161 被引量:59
标识
DOI:10.1158/1078-0432.ccr-20-3382
摘要

Abstract Purpose: Hepatocellular carcinoma (HCC) is characterized by high intertumor heterogeneity of genetic drivers. Two multitarget tyrosine kinase inhibitors (TKI), lenvatinib and sorafenib, are used as standard-of-care chemotherapeutics in patients with advanced HCC, but a stratification strategy has not been established because of a lack of efficacious biomarkers. Therefore, we sought biomarkers that indicate lenvatinib-susceptible HCC. Experimental Design: We performed genetic screening of HCC driver genes involved in TKI susceptibility using a novel HCC mouse model in which tumor diversity of genetic drivers was recapitulated. A biomarker candidate was evaluated in human HCC cell lines. Secreted proteins from HCC cells were then screened using mass spectrometry. Serum and tumor levels of the biomarker candidates were analyzed for their association and prediction of overall survival in patients with HCC. Results: We found that lenvatinib selectively eliminated FGF19-expressing tumors, whereas sorafenib eliminated MET- and NRAS-expressing tumors. FGF19 levels and lenvatinib susceptibility were correlated in HCC cell lines, and FGF19 inhibition eliminated lenvatinib susceptibility. Lenvatinib-resistant HCC cell lines, generated by long-term exposure to lenvatinib, showed FGF19 downregulation but were resensitized to lenvatinib by FGF19 reexpression. Thus, FGF19 is a tumor biomarker of lenvatinib-susceptible HCC. Proteome and secretome analyses identified ST6GAL1 as a tumor-derived secreted protein positively regulated by FGF19 in HCC cells. Serum ST6GAL1 levels were positively correlated with tumor FGF19 expression in patients with surgically resected HCC. Among patients with serum ST6GAL1-high HCC who underwent TKI therapy, lenvatinib therapy showed significantly better survival than sorafenib. Conclusions: Serum ST6GAL may be a novel biomarker that identifies lenvatinib-susceptible FGF19-driven HCC.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
a9902002发布了新的文献求助10
2秒前
Li完成签到,获得积分20
3秒前
3秒前
4秒前
yif发布了新的文献求助30
4秒前
4秒前
小灵通完成签到 ,获得积分10
5秒前
Ava应助catyew采纳,获得10
5秒前
Maggie发布了新的文献求助10
5秒前
可爱的函函应助朱小燕采纳,获得10
5秒前
wuhanfei发布了新的文献求助10
5秒前
flippedaaa发布了新的文献求助10
7秒前
7秒前
zpeng完成签到,获得积分10
7秒前
爆米花应助妍妍采纳,获得10
7秒前
wanci应助kdjm688采纳,获得10
8秒前
芽芽豆完成签到 ,获得积分10
8秒前
害羞靖完成签到,获得积分10
8秒前
8秒前
8秒前
solar@2030发布了新的文献求助10
9秒前
wuhanfei完成签到,获得积分10
9秒前
11秒前
12秒前
13秒前
林子青发布了新的文献求助30
14秒前
solar@2030完成签到,获得积分10
14秒前
魏少爷发布了新的文献求助10
15秒前
充电宝应助Bismarck采纳,获得10
16秒前
情怀应助醒醒采纳,获得50
16秒前
17秒前
18秒前
19秒前
19秒前
雨纷纷发布了新的文献求助10
19秒前
允期发布了新的文献求助10
20秒前
夏天无完成签到 ,获得积分10
20秒前
山鬼发布了新的文献求助10
20秒前
愉悦完成签到,获得积分10
21秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 1000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 310
The Moiseyev Dance Company Tours America: "Wholesome" Comfort during a Cold War 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3980224
求助须知:如何正确求助?哪些是违规求助? 3524191
关于积分的说明 11220260
捐赠科研通 3261653
什么是DOI,文献DOI怎么找? 1800792
邀请新用户注册赠送积分活动 879296
科研通“疑难数据库(出版商)”最低求助积分说明 807232